Suresh Mahabhashyam

Chief Tech/Sci/R&D Officer presso CORVUS PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profilo

Suresh Mahabhashyam is currently working as the Vice President-Clinical Development at Corvus Pharmaceuticals, Inc. He previously worked as the Senior Medical Director at Alexion Pharmaceuticals, Inc. from 2012 to 2015 and as the Vice President-Safety & Risk Management at Infinity Pharmaceuticals, Inc. from 2018 to 2019.
Dr. Mahabhashyam holds a graduate degree from the University of North Texas Health Science Center and a doctorate degree from Bangalore Medical College & Research Institute.

Posizioni attive di Suresh Mahabhashyam

Società	Posizione	Inizio
CORVUS PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/01/2020

Tutte le posizioni attive di Suresh Mahabhashyam

Precedenti posizioni note di Suresh Mahabhashyam

Società	Posizione	Fine
INFINITY PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2019
ALEXION PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/01/2015

Vedi nel dettaglio l'esperienza di Suresh Mahabhashyam

Formazione di Suresh Mahabhashyam

University of North Texas Health Science Center	Graduate Degree
Bangalore Medical College & Research Institute	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Suresh Mahabhashyam

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
CORVUS PHARMACEUTICALS, INC.	Health Technology
INFINITY PHARMACEUTICALS, INC.	Health Technology

Aziende private	1
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology